Nutanix Inc NTNX shares were slipping Friday morning in reaction to the fiscal fourth-quarter results released after the close Thursday.
The Analyst
Morgan Stanley analyst Katy Huberty maintained an Equal-weight rating on Nutanix and increased the price target from $55 to $57.
The Thesis
Expense growth at Nutanix was directed toward better segmenting the salesforce; improving the core platform; multicloud software; and future services, Huberty said in the Friday note. (See the analyst's track record here.)
The business investments led to a sharp reduction in Morgan Stanley's EPS and FCF estimates for 2019, the analyst said.
Yet Huberty said investors may do well to focus on the company's top-line and billings growth momentum near-term, especially due to stronger-than-expected software and support billings growth, accelerating HCI market growth and positive customer and partner feedback on the Nutanix software roadmap.
The investments are self-funded with the company's FCF in 2018, while 2019 is likely to be FCF-neutral, the analyst said.
Although the company's guidance that calls for Q1 revenue of $295 million to $310 million and billings of $370 million to $390 million appears soft, Huberty said the shortfall relative to her estimate is due to the faster run-off of hardware revenue and her 12.5 times bill-to-revenue ratio estimate, which is below the guidance for 12.6 times.
Morgan Stanley projects that Nutanix can sustain 40-percent billings growth over the next two years.
" ... We think investors will ultimately reward the company for investing and modestly raise [the price target] to $57," Huberty said.
The Price Action
Nutanix shares have gained about 72 percent year-to-date.
The stock was slipping 6.8 percent off the open to $56.66 Friday.
Related Links:
JPMorgan Upgrades Nutanix Ahead Of Q4 Report, Sees Balanced Risk-Reward Profile
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.